These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 10064389)
1. CA125 and thyroglobulin staining in papillary carcinomas of thyroid and ovarian origin is not completely specific for site of origin. Keen CE; Szakacs S; Okon E; Rubin JS; Bryant BM Histopathology; 1999 Feb; 34(2):113-7. PubMed ID: 10064389 [TBL] [Abstract][Full Text] [Related]
2. Value of mesothelial and epithelial antibodies in distinguishing diffuse peritoneal mesothelioma in females from serous papillary carcinoma of the ovary and peritoneum. Attanoos RL; Webb R; Dojcinov SD; Gibbs AR Histopathology; 2002 Mar; 40(3):237-44. PubMed ID: 11895489 [TBL] [Abstract][Full Text] [Related]
3. Expression of WT1, CA 125, and GCDFP-15 as useful markers in the differential diagnosis of primary ovarian carcinomas versus metastatic breast cancer to the ovary. Tornos C; Soslow R; Chen S; Akram M; Hummer AJ; Abu-Rustum N; Norton L; Tan LK Am J Surg Pathol; 2005 Nov; 29(11):1482-9. PubMed ID: 16224215 [TBL] [Abstract][Full Text] [Related]
4. Epithelial markers in thyroid carcinoma: an immunoperoxidase study. Wilson NW; Pambakian H; Richardson TC; Stokoe MR; Makin CA; Heyderman E Histopathology; 1986 Aug; 10(8):815-29. PubMed ID: 2428725 [TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical differentiation between primary adenocarcinomas of the ovary and ovarian metastases of colonic and breast origin. Comparison between a statistical and an intuitive approach. Lagendijk JH; Mullink H; van Diest PJ; Meijer GA; Meijer CJ J Clin Pathol; 1999 Apr; 52(4):283-90. PubMed ID: 10474521 [TBL] [Abstract][Full Text] [Related]
6. Tall cell variant of papillary thyroid carcinoma: a reassessment and immunohistochemical study with comparison to the usual type of papillary carcinoma of the thyroid. Ostrowski ML; Merino MJ Am J Surg Pathol; 1996 Aug; 20(8):964-74. PubMed ID: 8712296 [TBL] [Abstract][Full Text] [Related]
7. Thyroglobulin Determination in Fine Needle Aspiration Biopsy Washout of Suspicious Lymph Nodes in Thyroid Carcinoma Follow up. Achille G; Garrisi VM; Russo S; Guastamacchia E; Giagulli VA; Schirosi L; Daniele A; Tufaro A; Cafagna V; Centrone M; Simone G; Abbate I; Triggiani V Endocr Metab Immune Disord Drug Targets; 2017; 17(3):213-218. PubMed ID: 28558632 [TBL] [Abstract][Full Text] [Related]
8. Thyroid-associated antigens in routinely embedded carcinomas. Possibilities and limitations studied in 116 cases. Logmans SC; Jöbsis AC Cancer; 1984 Jul; 54(2):274-9. PubMed ID: 6202390 [TBL] [Abstract][Full Text] [Related]
9. Diffuse sclerosing variant of papillary carcinoma of the thyroid: a histological and immunohistochemical study of three cases. Chan JK; Tsui MS; Tse CH Histopathology; 1987 Feb; 11(2):191-201. PubMed ID: 2437003 [TBL] [Abstract][Full Text] [Related]
10. Serous papillary adenocarcinoma of the female genital organs and invasive micropapillary carcinoma of the breast. Are WT1, CA125, and GCDFP-15 useful in differential diagnosis? Moritani S; Ichihara S; Hasegawa M; Endo T; Oiwa M; Yoshikawa K; Sato Y; Aoyama H; Hayashi T; Kushima R Hum Pathol; 2008 May; 39(5):666-71. PubMed ID: 18339419 [TBL] [Abstract][Full Text] [Related]
11. Immunohistochemistry of thyroid carcinoma--an experience with thyroglobulin and calcitonin. Kavishwar VS; Phatak AM; Rege JD Indian J Pathol Microbiol; 1998 Apr; 41(2):163-7. PubMed ID: 9670628 [TBL] [Abstract][Full Text] [Related]
12. Tracing the origin of adenocarcinomas with unknown primary using immunohistochemistry: differential diagnosis between colonic and ovarian carcinomas as primary sites. Lagendijk JH; Mullink H; Van Diest PJ; Meijer GA; Meijer CJ Hum Pathol; 1998 May; 29(5):491-7. PubMed ID: 9596273 [TBL] [Abstract][Full Text] [Related]
13. Simultaneous occurrence of medullary and papillary carcinoma of the thyroid gland identified by fine needle aspiration. A case report. Merchant FH; Hirschowitz SL; Cohan P; Van Herle AJ; Natarajan S Acta Cytol; 2002; 46(4):762-6. PubMed ID: 12146049 [TBL] [Abstract][Full Text] [Related]
14. Utility of immunohistochemistry in the evaluation of necrotic thyroid tumors. Judkins AR; Roberts SA; Livolsi VA Hum Pathol; 1999 Nov; 30(11):1373-6. PubMed ID: 10571520 [TBL] [Abstract][Full Text] [Related]
15. WT1, monoclonal CEA, TTF1, and CA125 antibodies in the differential diagnosis of lung, breast, and ovarian adenocarcinomas in serous effusions. Zhu W; Michael CW Diagn Cytopathol; 2007 Jun; 35(6):370-5. PubMed ID: 17497661 [TBL] [Abstract][Full Text] [Related]
16. Thyroglobulin immunoreactivity in lymph node histiocytes: a potential diagnostic pitfall. Venkatraman L; Maxwell P; McCluggage WG J Clin Pathol; 2001 Apr; 54(4):314-6. PubMed ID: 11304850 [TBL] [Abstract][Full Text] [Related]
17. The expression of Wilms' tumour-1 and Ca125 in invasive micropapillary carcinoma of the breast. Lee AH; Paish EC; Marchio C; Sapino A; Schmitt FC; Ellis IO; Reis-Filho JS Histopathology; 2007 Dec; 51(6):824-8. PubMed ID: 18042071 [TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical confirmation of pulmonary papillary adenocarcinoma metastatic to ovaries. Householder J; Han A; Edelson MI; Eager JM; Rosenblum NG Arch Pathol Lab Med; 2002 Sep; 126(9):1101-3. PubMed ID: 12204061 [TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical analysis of thyroid adenomas with Hurthle cells. Kanthan R; Radhi JM Pathology; 1998 Feb; 30(1):4-6. PubMed ID: 9534199 [TBL] [Abstract][Full Text] [Related]
20. Thyroglobulin immunostaining in follicular thyroid carcinoma: relationship to the degree of differentiation and cell type. Harach HR; Franssila KO Histopathology; 1988 Jul; 13(1):43-54. PubMed ID: 3061922 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]